HIGHLIGHTS
- who: Yi Yan from the Department of Oncology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China have published the article: Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study, in the Journal: (JOURNAL)
- what: The authors aimed to assess the changes in peripheral blood lymphocyte subsets and their association with the therapeutic efficacy and clinical prognosis of advanced NSCLC patients treated with immunotherapy. The development of a dynamic, non-invasive and convenient approach to monitor the efficacy of ICIs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.